在疫情陰霾下，很多行業都在經歷休業和整頓，唯醫療行業卻越趨熱鬧，併購和上市的市場十分熱熾，強強聯手個案紛紛出現。
Under the gloom of the epidemic, many industries are undergoing closure, but the medical industry has become more lively. On August 2, Siemens Healthineers acquired all shares of Varian Medical Systems, a global leader in the field of cancer medicine, at a price of US$177.50 per share.
Following the Chinese biopharmaceutical company Everest Medicines, which was listed in Hong Kong in early October and raised approximately HKD 3.3 billion, Hong Kong’s IPO market soon ushered in an upstart in the biotech industry. RemeGen, founded in 2008 by Professor Fang Jianmin who graduated from Harvard, has announced its fund-raising plan for listing and is expected to win the throne of this year's largest biotech IPO.
在疫情阴霾下，很多行业都在经历休业和整顿，唯医疗行业却越趋热闹，并购和上市的市场十分热炽，强强联手个案纷纷出现。
Read full text:
Comments